Problem 138 - Cliffs Test Prep NCLEX-RN

Question

. Antiretroviral agents in the fusion class, such as infuvirtide (Fuzeon), inhibit HIV viral replication by: 1\. fusing the intracellular contents rendering them harmless. 2\. inhibiting the fusion of HIV positive cells to each other permitting macrophages to move in to phagocytose the positive cell. 3\. fusing the HIV positive cell with a killer T cell. 4\. inhibiting the HIV virus from fusing with a normal cell.

Step-by-Step Solution

Answer

Fusion inhibitors prevent HIV from merging with normal cells, so option 4 is correct.

Step 1: Understanding the Mechanism of Fusion Inhibitors

Fusion inhibitors, like enfuvirtide (Fuzeon), are a class of antiretroviral agents designed to prevent HIV from entering human cells. They achieve this by blocking the viral and cellular membranes from fusing together, which is an essential step for the virus to inject its genetic material into the cell.

Step 2: Analyzing the Choices

Let's examine each option: 1. This option suggests intracellular fusion, which is not the mechanism of fusion inhibitors. 2. This option discusses inhibiting fusion of positive cells and role of macrophages, which is unrelated to fusion inhibitors' primary function. 3. This option speaks of fusing an HIV-infected cell with a killer T cell, which is not correct. 4. This choice directly mentions inhibiting the fusion of the virus with a normal cell, matching the function of fusion inhibitors.

Step 3: Selecting the Correct Answer

Fusion inhibitors specifically prevent the virus from merging with host cells, stopping HIV's ability to replicate. Based on the analysis, option 4 is the correct mechanism described by fusion inhibitors.

Key Concepts

HIV Replication

HIV replication is a process that allows the HIV virus to multiply and spread in the body. When HIV enters the body, it targets the immune system's CD4 cells, which are a type of white blood cell crucial for fighting infections. Here's a simplified view of how it replicates:

• First, the HIV virus binds to a CD4 cell.
• It then fuses with the cell membrane and injects its RNA into the host cell.
• The viral RNA is converted into DNA by an enzyme called reverse transcriptase.
• This viral DNA gets integrated into the host cell's DNA, allowing the virus to take over the cell's machinery to produce more viral particles.
• Newly created viruses leave the host cell to infect other CD4 cells.

By continuously replicating in this manner, HIV weakens the immune system, leaving the body vulnerable to opportunistic infections and diseases. Understanding this process is vital for developing treatments that can effectively block one or more steps in the HIV life cycle.

Fusion Inhibitors

Fusion inhibitors are a specialized class of antiretroviral agents that play a critical role in preventing HIV from infecting human cells. Their main action is to stop the virus from merging with the host cell membrane:

• The virus normally attaches to a host cell via proteins on its surface.
• Fusion inhibitors, like enfuvirtide (Fuzeon), interfere with these proteins, preventing the viral envelope from fusing with the cell membrane.
• This blockade is crucial because, without fusion, the virus cannot inject its genetic material into the host cell, halting its replication cycle.

By ensuring that the virus stays outside the cell, fusion inhibitors prevent HIV from proliferating. Though fusion inhibitors are not a standalone solution for treating HIV, they are often part of a combination therapy that tackles various stages of the viral life cycle.

HIV Treatment Mechanism

The mechanism behind HIV treatment involves a variety of drugs working in tandem to halt the virus's replication process. Given the complexity of HIV, treatment typically involves a combination of different antiretroviral medications:

• Reverse Transcriptase Inhibitors: These drugs block the enzyme that converts viral RNA into DNA, preventing the integration of the virus into the host's genetic material.
• Protease Inhibitors: They inhibit another viral enzyme needed for cutting the virus's immature proteins into their final, functional form.
• Fusion Inhibitors: As discussed, they stop the virus from entering the host cells altogether.
• Integrase Inhibitors: These prevent the viral DNA from being inserted into the host cell's DNA.

By utilizing these different mechanisms, antiretroviral therapy aims to reduce the viral load in the body, maintain immune function, and minimize the chances of the virus developing drug resistance. Each drug class targets a different step in HIV replication, providing a multi-faceted approach to controlling the infection.